trending Market Intelligence /marketintelligence/en/news-insights/trending/g6vdaskbrgodlbt1fb1whq2 content esgSubNav
In This List

Deciphera appoints Agios executive to board

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Deciphera appoints Agios executive to board

Deciphera Pharmaceuticals, Inc. said it appointed Agios Pharmaceuticals Inc.'s chief commercial officer to its board.

The addition of Steven Hoerter to the Waltham, Mass.-based biopharmaceutical company's board increases its size to nine members from eight.

Deciphera expects Hoerter to assist the company as it advances its treatment, DCC-2618, for patients with gastrointestinal stromal tumors.

At Agios, Hoerter is responsible for the commercialization of the company's portfolio of medicines for oncology and rare genetic diseases.